Overview

Update
Total Equity Funding
$4.49M in 2 Rounds from 5 Investors
Most Recent Funding
$1.56M Venture on December 19, 2011
Headquarters:
Dublin, Dublin
Description:
Biosensia is a diagnostics company developing point-of-care platforms used for a variety of common biological sample types.
Categories:
Biotechnology, Health Diagnostics, Medical
Website:
http://www.biosensia.com
Social:

Company Details

Update

Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing.

RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications.

Its component chip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.

Funding Rounds (2) - $4.49M

Update
DateAmount / RoundValuationLead InvestorInvestors
Dec, 2011€1.2M / Venture3
Feb, 2008$2.93M / Venture4

Current Team (1)

Update

News (1)

Update
DateNews
Dec 19, 2011FinSMEs - FinSMEs

Offices/Locations (1)

Update
  • HQ

    Belfield Innovation Park

    Dublin, Dublin 4

    Ireland

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos